Latest Insider Transactions at Horizon Therapeutics Public LTD CO (HZNP)
This section provides a real-time view of insider transactions for Horizon Therapeutics Public LTD CO (HZNP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Horizon Therapeutics Public Ltd Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Horizon Therapeutics Public Ltd Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 28
2021
|
Paul W. Hoelscher EVP, CFO |
SELL
Open market or private sale
|
Direct |
8,575
-89.1%
|
$943,250
$110.0 P/Share
|
|
Dec 28
2021
|
Paul W. Hoelscher EVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,575
+47.12%
|
$128,625
$15.96 P/Share
|
|
Dec 13
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Bona fide gift
|
Indirect |
50
-0.13%
|
-
|
|
Dec 07
2021
|
Andy Pasternak EVP, Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,525
-6.53%
|
$152,500
$100.0 P/Share
|
|
Dec 03
2021
|
Paul W. Hoelscher EVP, CFO |
SELL
Bona fide gift
|
Direct |
1,049
-50.0%
|
-
|
|
Dec 01
2021
|
Miles W Mc Hugh Sr VP & Princ. Acctg Officer |
SELL
Open market or private sale
|
Direct |
79,484
-68.52%
|
$8,425,304
$106.62 P/Share
|
|
Dec 01
2021
|
Miles W Mc Hugh Sr VP & Princ. Acctg Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
79,484
+40.66%
|
$1,748,648
$22.14 P/Share
|
|
Nov 30
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
50,000
-3.1%
|
$5,100,000
$102.55 P/Share
|
|
Nov 08
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Bona fide gift
|
Indirect |
10,729
+22.1%
|
-
|
|
Nov 08
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Bona fide gift
|
Direct |
10,729
-54.07%
|
-
|
|
Nov 04
2021
|
Barry Moze EVP, Chief Admin. Officer |
SELL
Open market or private sale
|
Direct |
75,743
-10.81%
|
$8,483,216
$112.99 P/Share
|
|
Nov 04
2021
|
Barry Moze EVP, Chief Admin. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
75,743
+12.18%
|
$1,211,888
$16.14 P/Share
|
|
Nov 04
2021
|
Andy Pasternak EVP, Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
30,168
-12.72%
|
$3,408,984
$113.02 P/Share
|
|
Nov 04
2021
|
Andy Pasternak EVP, Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,251
+30.29%
|
$674,279
$29.52 P/Share
|
|
Nov 01
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-1.09%
|
$2,950,000
$118.8 P/Share
|
|
Nov 01
2021
|
Andy Pasternak EVP, Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,503
-15.38%
|
$649,354
$118.29 P/Share
|
|
Nov 01
2021
|
Andy Pasternak EVP, Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,421
+25.77%
|
-
|
|
Oct 27
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,729
+35.09%
|
$75,103
$7.61 P/Share
|
|
Oct 26
2021
|
Timothy P Walbert Chairman, President and CEO |
BUY
Bona fide gift
|
Indirect |
100,300
+50.0%
|
-
|
|
Oct 26
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Bona fide gift
|
Indirect |
100,300
-76.28%
|
-
|
|
Sep 30
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
50,000
-2.7%
|
$5,500,000
$110.92 P/Share
|
|
Sep 21
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
46,271
-83.54%
|
$5,089,810
$110.0 P/Share
|
|
Sep 21
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
46,271
+45.52%
|
$323,897
$7.61 P/Share
|
|
Sep 17
2021
|
Timothy P Walbert Chairman, President and CEO |
BUY
Bona fide gift
|
Indirect |
218,241
+47.83%
|
-
|
|
Sep 17
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Bona fide gift
|
Direct |
218,241
-13.82%
|
-
|
|
Sep 17
2021
|
Brian K Beeler EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
28,143
-30.95%
|
$3,011,301
$107.91 P/Share
|
|
Sep 09
2021
|
Andy Pasternak EVP, Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
23,250
-25.45%
|
$2,511,000
$108.05 P/Share
|
|
Sep 09
2021
|
Andy Pasternak EVP, Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,250
+33.28%
|
$674,250
$29.52 P/Share
|
|
Sep 03
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Bona fide gift
|
Indirect |
4,042
+12.99%
|
-
|
|
Sep 03
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Bona fide gift
|
Direct |
4,042
-30.72%
|
-
|
|
Aug 27
2021
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,435
+0.87%
|
$163,570
$22.14 P/Share
|
|
Aug 25
2021
|
Paul W. Hoelscher EVP, CFO |
BUY
Bona fide gift
|
Indirect |
6,163
+3.34%
|
-
|
|
Aug 25
2021
|
Paul W. Hoelscher EVP, CFO |
SELL
Bona fide gift
|
Direct |
6,163
-74.6%
|
-
|
|
Aug 16
2021
|
Brian K Beeler EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
74,898
-45.17%
|
$7,939,188
$106.0 P/Share
|
|
Aug 16
2021
|
Brian K Beeler EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
65,857
+28.43%
|
$1,448,854
$22.14 P/Share
|
|
Aug 05
2021
|
Elizabeth H.Z. Thompson EVP, Research & Development |
SELL
Open market or private sale
|
Direct |
7,542
-34.71%
|
$799,452
$106.34 P/Share
|
|
Jul 30
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-1.45%
|
$2,550,000
$102.11 P/Share
|
|
Jul 28
2021
|
Brian K Beeler EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,573
-2.51%
|
$262,446
$102.5 P/Share
|
|
Jul 28
2021
|
Brian K Beeler EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
5,806
+5.36%
|
-
|
|
Jul 28
2021
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
3,599
-3.81%
|
$367,098
$102.5 P/Share
|
|
Jul 28
2021
|
Michael A. Des Jardin EVP, Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
7,257
+7.13%
|
-
|
|
Jul 28
2021
|
Paul W. Hoelscher EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,858
-31.83%
|
$393,516
$102.5 P/Share
|
|
Jul 28
2021
|
Paul W. Hoelscher EVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
8,708
+41.81%
|
-
|
|
Jul 28
2021
|
Barry Moze EVP, Chief Admin. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,215
-4.08%
|
$327,930
$102.5 P/Share
|
|
Jul 28
2021
|
Barry Moze EVP, Chief Admin. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,257
+8.42%
|
-
|
|
Jul 28
2021
|
Andy Pasternak EVP, Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,858
-14.18%
|
$393,516
$102.5 P/Share
|
|
Jul 28
2021
|
Andy Pasternak EVP, Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,708
+24.24%
|
-
|
|
Jul 28
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,215
-19.64%
|
$327,930
$102.5 P/Share
|
|
Jul 28
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,257
+30.71%
|
-
|
|
Jul 28
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,432
-1.75%
|
$1,574,064
$102.5 P/Share
|